Doctropicale
ActiveSummary
Doctropicale has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €164,499 and a net result of €68,720. Equity is growing by about 38% per year across the filed financial years. Its solvency ranks better than 83% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
25-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 25 days late
2025
31-12
Financial
Highest result from 2022 to 2025net €68,720 ▲320%
Operating result €85,765, net result €68,720, both a record.
31-12
Financial
Equity above €150,000equity €164,499 ▲66%
A profit in every financial year since 2022 builds equity to €164,499.
25-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Weakest financial yearnet €16,350 ▼38.7%
Net result drops to €16,350, the lowest in the series; recovery starts the following year.
26-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
28-04
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.